ArticleScientific reports2025
Exploring the molecular mechanisms of comorbidity between thyroid cancer and breast cancer through multi-omics data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bioinformatics screening identifies USP9X as a pathogenic gene underlying thyroid and breast cancer comorbidity.Journal of molecular histology · 2026Article
- Ethnopharmacological evaluation and metabolic mechanism of Sanjie Xiaoliu Granule in breast cancer with depression.Biological procedures online · 2026Article
- Sex Differences in Cancer Immunotherapy-Clinical Evidence and Mechanisms With a Focus on NSCLC.Immunological reviews · 2026Review
- Synchronous papillary thyroid carcinoma and cervical lymph node metastasis of breast cancer: a case report.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid Cancer (TC) and Breast Cancer (BC) are highly prevalent malignancies in women, and studies have shown that they may be related by molecular mechanisms. However, the molecular regulatory networks and key genes involved in the co-occurrence of the two tumors are still unclear. This study aims to explore potential diagnostic markers and therapeutic targets using bioinformatics. The TC (GSE3467) and BC (GSE61304) datasets were downloaded from the NCBI GEO database, and the data were analyzed for differentially expressed genes (DEGs) using the limma package of the R language. Disease-related gene modules were screened by weighted gene co-expression network analysis (WGCNA), and the hub genes were further screened by computational ranking by semantic similarity. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyzed the biological functions of hub genes. Immune infiltration analysis was performed to reveal the association and expression correlation between the hub genes and immune cells and to explore the relationship between the hub genes and genes related to immunity, autophagy, and ferroptosis. In addition, mRNA-miRNA regulatory networks were constructed, and key regulatory miRNAs were screened by network topology analysis. Potential therapeutic drugs were screened using online tools, and drug molecules were docked in parallel. A total of 58 overlapping differential genes associated with TC and BC were identified, 27 common genes were obtained by intersection with 133 common genes identified by WGCNA, and seven hub genes were obtained by screening. We found that hub genes in both diseases are associated with autophagy, and ferroptosis. Six key regulatory miRNAs were screened, and six potential therapeutic agents were identified using Enrichr and PubChem databases. This bioinformatics study elucidated the possible co-occurrence mechanisms of TC and BC, providing new insights into their underlying pathogenesis and exploring new targets for medical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.